AMIX vs. CVRX, CLPT, QIPT, TELA, BWAY, KRMD, BLUA, SRTS, HSAQ, and ALUR
Should you be buying Autonomix Medical stock or one of its competitors? The main competitors of Autonomix Medical include CVRx (CVRX), ClearPoint Neuro (CLPT), Quipt Home Medical (QIPT), TELA Bio (TELA), BrainsWay (BWAY), KORU Medical Systems (KRMD), BlueRiver Acquisition (BLUA), Sensus Healthcare (SRTS), Health Sciences Acquisitions Co. 2 (HSAQ), and Allurion Technologies (ALUR). These companies are all part of the "surgical & medical instruments" industry.
CVRx (NASDAQ:CVRX) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends, community ranking and profitability.
CVRx received 16 more outperform votes than Autonomix Medical when rated by MarketBeat users.
In the previous week, CVRx and CVRx both had 2 articles in the media. Autonomix Medical's average media sentiment score of 0.73 beat CVRx's score of 0.62 indicating that CVRx is being referred to more favorably in the media.
Autonomix Medical has lower revenue, but higher earnings than CVRx.
CVRx currently has a consensus target price of $16.60, indicating a potential upside of 138.85%. Given Autonomix Medical's higher possible upside, analysts clearly believe CVRx is more favorable than Autonomix Medical.
Autonomix Medical has a net margin of 0.00% compared to Autonomix Medical's net margin of -123.58%. CVRx's return on equity of 0.00% beat Autonomix Medical's return on equity.
75.3% of CVRx shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 18.9% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
CVRx beats Autonomix Medical on 7 of the 11 factors compared between the two stocks.
Get Autonomix Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Autonomix Medical Competitors List
Related Companies and Tools
